Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Dupuytren Research Group is a non-profit medical research organization dedicated to finding a cure for Dupuytren disease and related fibrotic conditions. The organization's primary focus is the International Dupuytren Data Bank (IDDB), a large-scale clinical study designed to identify genetic markers and biomarkers for disease progression. By analyzing data from thousands of patients, the group aims to develop personalized treatment strategies and preventative measures. Their work facilitates collaboration between patients, clinicians, and researchers to advance the understanding of the biological mechanisms underlying palmar and plantar fibromatosis.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Dupuytren Research Group.